Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse

This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse...

Full description

Saved in:
Bibliographic Details
Main Authors: Tania Ahuja, Ofole Mgbako, Caroline Katzman, Allison Grossman
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Psychiatry
Online Access:http://dx.doi.org/10.1155/2018/9864285
Tags: Add Tag
No Tags, Be the first to tag this record!